文献速递其他结缔组织病

干燥综合征血清蛋白组特征与腺体炎症及自身抗体相关

A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's disease.
PubMed 文献 · Ann Rheum Dis · 2025-12-12

该研究通过邻近延伸分析技术检测干燥综合征(SjD)患者唾液腺提取物和血清蛋白组,发现血清中27种蛋白与SjD相关,其中16种在挪威队列中验证。由16种验证蛋白构建的「干燥蛋白评分」与唾液腺灶性评分相关,区分SjD与健康对照的曲线下面积为0.888(特异性89%,敏感性76%)。

要点

  • 血清蛋白组改变可反映唾液腺局部炎症并与遗传、血清学特征相关
  • 16种验证蛋白水平随ANA、抗Ro/SSA、抗La/SSB抗体阳性呈阶梯式升高
  • 干燥蛋白评分或可作为SjD无创诊断生物标志物

核心结论

  • 研究定义了反映局部腺体炎症并与遗传和血清学特征相关的验证性血清蛋白组特征,干燥蛋白评分有望作为SjD无创诊断生物标志物。

研究设计与样本

  • 研究纳入SjD患者(n=81)和 sicca 对照(n=19)的配对唾液腺提取物和血清样本,以及瑞典队列(SjD n=456;对照 n=141)和挪威队列(SjD n=233;对照 n=137)的血清样本,采用邻近延伸分析技术检测蛋白组。
  • 患者按抗核抗体(ANA)、抗Ro/SSA、抗La/SSB自身抗体及腺外表现分层,并整合人类白细胞抗原(HLA)等位基因评估遗传关联。

主要发现

  • 唾液腺提取物的蛋白组改变较血清更显著。
  • 瑞典发现队列中27种血清蛋白与SjD相关,其中16种在挪威验证队列中得到验证。
  • 包括已知生物标志物CXCL10和CXCL13及较新的溶酶体相关膜糖蛋白3和细胞毒性及调节性T细胞分子在内的多种蛋白与腺外表现相关,尤其是肺部受累。
  • 16种验证蛋白水平在血清学亚组间呈阶梯式升高,从ANA阴性最低到抗Ro/SSA和抗La/SSB双阳性最高,并与风险等位基因HLA-DRB1*03和DRB1*15相关。
  • 基于16种验证蛋白的复合「干燥蛋白评分」与唾液腺灶性评分相关,区分SjD与健康对照的曲线下面积为0.888(特异性89%,敏感性76%)。

关键数值与推荐

  • 干燥蛋白评分区分SjD与健康对照的曲线下面积为0.888,特异性89%,敏感性76%。

临床怎么用

  • 干燥蛋白评分或可作为非侵入性生物标志物辅助SjD诊断,尤其适用于需要评估腺体炎症和血清学特征的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify serum and salivary gland proteomic biomarkers in primary Sjögren's disease (SjD), evaluate their correlation with tissue inflammation, and relate findings to clinical, autoantibody, and genetic profiles. METHODS: Paired salivary gland extracts and serum samples from patients with SjD (n = 81) and sicca controls (n = 19), and serum from larger Swedish (SjD n = 456; controls n = 141) and Norwegian (SjD n = 233; controls n = 137) cohorts, were analysed using proximity extension assay technology. Patients were stratified by antinuclear antibodies (ANA), anti-Ro/SSA, anti-La/SSB autoantibodies, and extraglandular manifestations. Human leukocute antigen (HLA) alleles were integrated to assess genetic associations. RESULTS: Proteomic analysis revealed more pronounced alterations in the salivary gland extracts compared to serum. In serum, 27 proteins were associated with SjD in the Swedish discovery cohort, of which 16 proteins were validated in the Norwegian replication cohort. Several proteins including both described biomarkers C-X-C motif chemokine ligand (CXCL)10 and CXCL13 and more novel lysosome-associated membrane glycoprotein 3 and cytotoxic and regulatory T cell molecule correlated with extraglandular manifestations, particularly pulmonary involvement. Levels of the 16 validated proteins increased in a stepwise fashion across serological subgroups, from lowest in ANA negative to highest in anti-Ro/SSA and anti-La/SSB double-positive patients and were linked to risk alleles HLA-DRB1*03 and DRB1*15. A composite 'Sjögren protein score' based on the 16 validated proteins correlated with salivary gland focus score and successfully distinguished SjD from healthy controls (area under the curve 0.888; 89% specificity, 76% sensitivity). CONCLUSIONS: We define a validated serum proteomic signature that reflects local glandular inflammation and correlates with genetic and serological features. The 'Sjögren protein score' holds promise as a noninvasive biomarker for the diagnosis of SjD.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Björk A, Mofors J, Meneghel L, et al. A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's disease. Ann Rheum Dis. 2025. PMID: 41387154. doi:10.1016/j.ard.2025.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。